The largest database of trusted experimental protocols

Platelia aspergillus ag kit

Manufactured by Bio-Rad
Sourced in France, United Kingdom, China, United States

The Platelia™ Aspergillus Ag kit is a diagnostic tool used to detect the presence of Aspergillus galactomannan antigen in patient samples. It is designed to aid in the diagnosis of invasive aspergillosis, a serious fungal infection.

Automatically generated - may contain errors

5 protocols using platelia aspergillus ag kit

1

Fungal Infection Diagnostic Procedures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diagnostic procedures for the diagnosis of IFD routinely used galactomannan enzyme immunoassay in serum, bronchoalveolar lavage (BAL), and cerebrospinal fluid (CSF) besides histology, direct examination and culture on clinical specimens according to standard method [34 (link)]. Briefly, identification of fungi was done using classical phenotypically methods until implementation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS, Microflex, Bruker Daltonics): yeasts were identified using MALDI Biotyper V1.3 Software (Bruker Daltonics) since April 2013 and filamentous fungi were identified at the species level using an extended reference spectra library [35 (link)] since October 2014. Mucormycosis diagnosis was carried out using PCR on serum in the Mycology Laboratory of Besancon University Hospital [36 (link)]. Serum GM tests were performed twice a week until neutropenia recovery, yielding a total of 2297 collected sera. Galactomannan detection was performed using the Platelia™ Aspergillus Ag kit (Bio-Rad Laboratories, Marnes-la-Coquette, France) according to the manufacturer's instructions. Serum, BAL and CSF were treated under a class 2 biological safety cabinet. Positive GM tests were controlled on the same sample and always verified on another sample. GM assay in BAL were performed in duplicate.
+ Open protocol
+ Expand
2

Neutrophil Depletion and Doxycycline Treatment in Aspergillosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight- to ten-week-old female BALB/c mice (Charles River, Senneville, Quebec, Canada) were neutrophil depleted by intraperitoneal injection of 200 μg of anti-Ly6G antibody (clone 1A8, BioXcell) every 48 h, beginning 1 day prior to infection. Mice were then infected intratracheally with 1 × 107A. fumigatus conidia in 50 μl of PBS plus 0.01% (vol/vol) Tween 80 (PBS-T) or with PBS-T alone for uninfected controls. Doxycycline (Sigma) was administered by intraperitoneal injection at doses ranging from 10 to 25 mg/kg by oral gavage (100 mg/kg Doxycycline every 12 h) or by supplementation of drinking water (500 μg/ml Doxycycline and 5% sucrose) and chow (625 mg/kg Doxycycline; Envigo-Teklad) as indicated. Doxycycline-free control mice were given equal volumes of PBS. Serum Doxycycline levels were determined by ultra-high-performance liquid chromatography coupled to mass-spectrometry (uHPLC-MS/MS) analyses at the Drug Discovery Platform of the Research Institute of the McGill University Health Centre (Montreal, Canada). For fungal burden studies, mice were euthanized 36 h postinfection, and their lungs were harvested and homogenized in PBS. The fungal burden was determined by quantification of pulmonary galactomannan (GM) content using a Platelia Aspergillus Ag kit (Bio-Rad) as previously described (55 (link)).
+ Open protocol
+ Expand
3

Fungal Antigen Detection Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
GM antigen detection in serum and BAL fluid and BDG antigen detection in serum were performed exactly as described previously (25 (link)), using the Platelia Aspergillus Ag kit (Bio-Rad Laboratories Ltd., Watford, UK) and the Fungitell assay (Associates of Cape Cod, Inc., East Falmouth, MA, USA), respectively. Cutoff values for positivity were >80 pg/ml (BDG), index value >0.5 (GM on serum) and index value >1.0 (GM on BAL fluid) as suggested previously (25 (link), 26 (link)).
+ Open protocol
+ Expand
4

Comprehensive Respiratory Pathogen Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples of patients were collected and tested for the IgM of respiratory tract pathogens with Pneumoslide IgM kit (Vircell, Spain), including human respiratory syncytial virus, influenza A virus (subtypes H1N1 and H3N2), influenza B virus, parainfluenza virus 1/2/3, metapneumovirus, common coronavirus, Epstein-Barr virus, cytomegalovirus, rhinovirus, adenovirus, and bocavirus, as well as Legionella pneumophila serum type I, Mycoplasma pneumonia, and Chlamydia pneumoniae. Nasopharyngeal secretions were tested for nucleic acids of 13 respiratory pathogens (Health Gene Technologies, Ningbo, China). Sputum culture was performed to identify bacterial and fungal co-infection. The fungal examination was performed with Fungus (1-3)-β-D-Glucan kit (Dynamiker Biotechnology, Tianjin, China) and Platelia aspergillus Ag kit (Bio-rad, USA).
+ Open protocol
+ Expand
5

Aspergillus Galactomannan Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
BAL and TA samples were routinely processed for bacterial and fungal cultures, and gram and potassium hydroxide (KOH) stains were performed directly on arrival to the Clinical Microbiology Laboratory. TA samples were not treated with mucolytics. GM detection was performed in 300 μL of BAL and AT samples using the Platelia™ Aspergillus Ag kit, BioRad Lab®, Redmond, WA, USA. following the manufacturer's recommendations. The interpretation of positive GM was as follows: in BAL with an OD index ≥ 1.0, in TA with an OD ≥ 2.0 index (Roman-Montes, C. M., 2021) and in serum sample with GM index >0.5 (Roman-Montes et al., 2021 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!